Publication | Closed Access

Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab

Breast OncologyMedicineBrain MetastasisPathologyBreast CancerDisease RecurrenceCancer TreatmentOncologyRadiation OncologyRisk FactorsHealth Sciences